Teriparatide

Therapeutic Group

Drugs For Treatment Of Bone Diseases

Indication Dosage

Treatment Of Osteoporosis In Postmenopausal Women And In Men At Increased Risk Of Fractures, Treatment Of Corticosteroid-induced Osteoporosis: 

By Sc Inj: 

  • Adult: 20 Micrograms Daily For Maximum Duration Of Treatment 24 Months (course Not To Be Repeated)

Content

  • Inj: Per ml: Teriparatide 250 Mcg; 3 ml Pre-Filled Pen For 28 Doses.

Pregnancy

Contraindicated

Stability

  • Recombinant Parathyroid Hormone and Analogue

Contra Indications

  • Bone Metastases, Hyperparathyroidism Metabolic Bone Diseases, Paget's Disease, Pre-existing Hypercalcaemia, Previous Radiation, Therapy To The Skeleton, Skeletal Malignancies, Unexplained Raised Alkaline Phosphatase

Precautions

  • Bone Metastases, Hyperparathyroidism Metabolic Bone Diseases, Paget's Disease, Pre-existing Hypercalcaemia, Previous Radiation, Therapy To The Skeleton, Skeletal Malignancies, Unexplained Raised Alkaline Phosphatase

Lactation

  • Contraindicated

Side Effects

  • Anaemia
  • Arthralgia
  • Asthenia
  • Depression
  • Dizziness
  • Dyspnea
  • Fatigue
  • Gi Disorders
  • Haemorrhoids
  • Headache
  • Increased Sweating
  • Muscle Cramps
  • Myalgia
  • Nausea
  • Palpitation
  • Reflux
  • Sciatica
  • Vertigo
  • Hypercalcaemia
  • Injection-site Reactions
  • Urinary Disorders.
  • Rare: Hypersensitivity Reactions

Available Brands